secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-09-11T13:29:03+00:00
Accession:  0001213900-26-099018
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative VP of R&D resigns claiming Good Reason; company disputes severance demand
--------------------------------------------------------------------------------

- Mr. Silva resigned as VP of R&D effective Sept 4, 2026, asserting 'Good Reason' under employment agreement due to alleged Change in Control from June 2026 board changes.
- Silva demands ~$1.29M cash severance, equity award acceleration, and benefit continuation; company does not accept validity of agreement or his characterizations.
- Board acknowledges resignation for records but reserves all rights; only accrued unpaid salary to be paid pending investigation.
- Board investigating circumstances around Employment Agreement and agreements with former CEO and former CFO before any payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026099018/0001213900-26-099018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026099018/ea0305246-8k_biore.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-099018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer